|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 444 NORTH CAPITOL STREET, NW, #625 |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 32054-12
|
||||||||
|
6. House ID# 304560000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: John Knapp |
Date | 10/14/2022 4:02:13 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5487 - Value in Health Care Act of 2021
S. 2652/H.R. 5067 - Preserving Patient Access to Home Infusion Act
H.R. 6520 - The Medical and Health Stockpile Accountability Act of 2022, automated data collection infrastructure for healthcare supply chain
S.308 / H.R.1436 - PPE in America Act
S.1260 - United States Innovation and Competition Act of 2021
S. 936 / H.R. 5502 - INFORM Consumers Act
S. 2648 - Rural ACO Improvement Act
S. 1574/H.R.5632 - Long-Term Care Pharmacy Definition Act
H.R. 7053/S. 3792 - Hospital Inpatient Services Modernization Act
S. 834 / H.R. 2256 - Resident Physician Shortage Reduction Act of 2021
H.R.3173 / S 3018 - Improving Seniors Timely Access to Care Act of 2021
H.R. 3746 - Accountable Care in Rural America Act
H.R. 959 / S. 364 - Black Maternal Health Momnibus Act of 2021
H.R. 4387 / S. 1675 - Maternal Health Quality Improvement Act of 2021
S. 168 / H.R. 708 - Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
S. 150 - Ensuring Parity in MA for Audio Only-Telehealth Act
S. 3799 - The PREVENT Pandemics Act
S. 3416 - The Protecting Patients from Counterfeit Medical Devices Act
S. 3493 - Drug Shortages Shelf Life Extension Act
H.R. 4521 - America COMPETES Act of 2022
S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act
H.R.3684 - Infrastructure Investment and Jobs Act
H.R. 4735/S. 2493 - The Provider Relief Extension Act
H.R. 3589 - Better Way for Providers To Repay Act of 2021
H.R. 3203 / S. 773 - To allow hospitals that were participating in or applied for the 340B drug discount program before the public health emergency to temporarily maintain eligibility
H.R. 7961 - Safety from Violence for Healthcare Employees (SAVE) Act
H.R. 7410 - The American Made Medicine Act
Hospital Infrastructure Support
FDA User Fee Reauthorization Bills
Healthcare workforce (Graduate medical education , health professional training programs, recruitment and retention incentives)
Medicare provider payment cuts (Medicare sequestration cuts, physician fee schedule 3% reduction due to evaluation & management code increases/budget neutrality adjustment, Pay-as-You-Go reductions due to American Rescue Plan)
HHS FY 2023 appropriations - Removal of a ban on using federal funds for implementing a unique patient identification system (Section 510) and funding for Childrens Hospitals Graduate Medical Education (CHGME) Program
NQF/Quality Measurement funding authorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Emergency Management Agency (FEMA), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), Centers For Medicare and Medicaid Services (CMS), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Blair |
Childs |
|
|
|
Shara |
Siegel |
|
|
|
Soumi |
Saha |
|
|
|
John |
Knapp |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |